Ledger.Open graph →
SEC Form D · filed June 2, 2021

Allyx Therapeutics, Inc

Offering
$8.0M
Sold
$7.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW HAVEN, CT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Timothy P. Siegert · Hamden, CTExecStephen Strittmatter · Durham, CTExec · DirectorRobert A. Bettigole · New Haven, CTDirectorGregory P. Ho · New York, NYDirectorPaul P. Fonteyne · Westport, CTDirectorStephen Bloch · New Haven, CTExec · DirectorLeon N. Bressler · London, United KingdomDirectorHerbert Frazier · Boston, MAExecDaniel Conant · Shepherdstown, WVDirectorSteve Sershen · Chester, SDDirectorAner Ben-Ami · Shepherdstown, WVExec · DirectorKiran Bhatraju · Shepherdstown, WVExec · DirectorW. C. Bade · Ann Arbor, MIDirectorYihe Zhang · Hoboken, NJDirectorDonald R. Carter · Rancho Santa Fe, CAExec · DirectorAdrian Martin-Jimenez · Grand Cayman, Cayman IslandsExec · DirectorPablo Defelippe · Luxembourg, LuxembourgExecEdward Patton · Concord, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗